Nina Oberbeck

Nina Oberbeck is a highly experienced professional in the field of molecular biology and preclinical translation, currently serving as the Senior Director of Preclinical Translation at Gate Bioscience since January 2022. Prior roles include Director of Preclinical Translation at Maze Therapeutics from September 2019 to January 2022, and various scientific positions at Genentech, where notable research included work on the RIPK4–IRF6 signaling axis, as well as postdoctoral roles at MRC Laboratory of Molecular Biology. Nina Oberbeck earned a Doctor of Philosophy (PhD) in Molecular Biology, a Master of Science (MS) in Biochemistry and Molecular Biology, and a Bachelor of Arts (BA) in Natural Sciences, all from the University of Cambridge.